Company Search:
Advanced Search
Sponsored Links
Shenzhen Neptunus Bioengineer Company Snapshot
Shenzhen Neptunus Bioengineer operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Shenzhen Neptunus Bioengineer with three other companies in this sector in China: Shanghai Fosun Pharmaceutical (Group) Company Limited (2016 sales of 14.51 billion Chinese Renmimbi [US$2.29 billion] of which 70% was Pharmaceutical Manufacturing and R&D), Harbin Pharmaceutical Group Company Limited (14.13 billion Chinese Renmimbi [US$2.23 billion] of which 64% was Medicine Trade), and Tasly Pharmaceutical Group Company Limited (13.95 billion Chinese Renmimbi [US$2.21 billion] of which 51% was Medicine Commerce).

Sales Analysis. During the year ended December of 2016, sales at Shenzhen Neptunus Bioengineer were 13.61 billion Chinese Renmimbi (US$2.15 billion). This is an increase of 22.4% versus 2015, when the company's sales were 11.12 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Shenzhen Neptunus Bioengineer (and since 2011, sales have increased a total of 156%). Sales of Pharmaceutical Appliance saw an increase that was more than double the company's growth rate: sales were up 78.5% in 2016, from 645.61 million Chinese Renmimbi to 1.15 billion Chinese Renmimbi. Not all segments of Shenzhen Neptunus Bioengineer experienced an increase in sales in 2016: sales of Other Operating fell 32.4% to 23.94 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales). Shenzhen Neptunus Bioengineer also experienced decreases in sales in Pharmaceutical Manufacturing (down 8.4% to 437.51 million Chinese Renmimbi) .
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Shenzhen Neptunus Bioengineer
  Stock Performance Chart for Shenzhen Neptunus Bioengineer
  Stock Data: Recent Stock Performance:
  Current Price (3/9/2018): 6.01
(Figures in Chinese Renmimbi)
1 Week 7.5%   13 Weeks 13.2%  
4 Weeks 0.2%   52 Weeks -6.1%  
Shenzhen Neptunus Bioengineer Key Data:
  Ticker: 000078 Country: China
  Exchanges: SZN Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 13,605,660,126
(Year Ending Jan 2017).
Employees: 5,616
  Currency: Chinese Renmimbi Market Cap: 15,906,145,675
  Fiscal Yr Ends: December Shares Outstanding: 2,646,613,257
  Share Type: A Gu Closely Held Shares: 1,249,001,444
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.